FDA Drugs (New Approvals & NDA)Original article
October 30, 2026: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement - 10/30/2026
AdComNeutral
AI Analysis
Summary
FDA Dermatologic and Ophthalmic Drugs Advisory Committee meeting scheduled for October 30, 2026. No specific drug, indication, or outcome information provided in the announcement.
Importance:3/10
Sentiment:
0.00
advisory_committeedermatologyophthalmologyregulatory
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 25, 2026 1:58 PM